US University started a clinical trial of Preventing Weight Gain Among Those Who Decline Behavioral Weight Loss Treatment
The University of Florida is starting a new clinical trial of Preventing Weight Gain Among Those Who Decline Behavioral Weight Loss Treatment.
To prevent weight gain while overcoming these common barriers to engaging in weight management interventions, we propose an intervention that prescribes self-weighing but does not prescribe changes in diet or physical activity behaviors or require attendance at didactic-focused meetings. The potential of self-weighing to promote weight management is supported both by self-regulatory theory and empirical research. Promoting self-weighing may activate participants' self-regulatory skills, leading to spontaneous decisions to reduce calorie intake or increase physical activity, thus preventing further weight gain. The proposed intervention will also provide individuals with text message-based feedback to promote continued self-weighing and to motivate engagement with evidence-based resources for weight management at a time when they may be more open to using these resources-e.g., after experiencing a small weight gain. The current proposal will investigate the feasibility and acceptability of this low burden self-weighing intervention in order to prepare for a fully-powered, pragmatic randomized controlled trial.
The clinical trial started in January 25, 2021 and will continue throughout July 30, 2022.
The inclusion parameters are:
- Age 18-70
- Body weight recorded in EHR in the prior month from a primary care setting.
- Last BMI in EHR either ≥30 kg/m2 or between 25.0-29.9 kg/m2 with documented weight-related comorbidity (hypertension, type II diabetes, pre-diabetes, dyslipidemia, sleep apnea).
- Weight ≤ 375 lbs.
- Has not engaged in self-weighing ≥ 5 times per week on average over prior month.
- Not pregnant, breastfeeding, or planning to become pregnant in next 6 months.
- Not currently undergoing radiation or chemotherapy for cancer.
- No history of eating disorders.
The full list can be viewed at the link below.
The contacts and locations are the UF Health at the University of Florida, Gainesville, Florida, United States.
For more details: https://ichgcp.net/clinical-trials-registry/NCT04751656
